• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / PET positive esophageal leiomyoma: a case series and literature review

PET positive esophageal leiomyoma: a case series and literature review

James Kurtz, Rene Borscheid, Edward Cho, Houssam Osman, Rohan Jeyarajah. Methodist Richardson Medical Center

Introduction: Esophageal leiomyomas are rare, benign tumors that can be adequately treated with limited resection or enucleation. Distinguishing a leiomyoma from a more aggressive entity can present a diagnostic challenge. It has been suggested that positron emission tomography (PET) scanning can help determine the likelihood of an invasive cancer.

Case series: We present a series of two patients with large esophageal leiomyomas that had increased uptake of 18F-fluorodeoxyglucose on PET scan. Both patients underwent transhiatal esophagectomy.

Patient A had a pre-operative endoscopic ultrasound biopsy that showed spindle-cell neoplasm in the esophageal mass. He also had Barrett’s esophagus with high grade dysplasia. Intra-operative frozen section also showed spindle cells and was labeled as probable leiomyoma but cannot rule out sarcoma. After discussion with operative team, pathologist, and radiologist that read the PET/CT scan the decision was made to perform Transhiatal esophagectomy. The final pathology showed an 8.8cm leiomyoma as well as evidence of Barrett’s esophagus with high grade dysplasia. The post-operative course was uneventful and the patient was discharged on post-operative day number nine.   

Patient B had a history of achalasia treated with prior thoracic esophagomyotomy who was referred for reflux refractory to balloon dilations and medications. Workup including CT scan, upper GI contrast study, endoscopic ultrasound, PET/CT, and manometry revealed a distal esophageal mass that was PET avid. His endoscopic biopsy showed no malignant cells. Intra-operative frozen section was described as leiomyoma versus gastrointestinal stromal tumor. Final pathology was consistent with 8.5cm leiomyoma that stained positive for smooth muscle and desmin. The post-operative course was uneventful and the patient was discharged home on post-operative day number eight.

Conclusions: The patients in this series had large, symptomatic esophageal leiomyomas with a positive PET scan and underwent an operation fit for an invasive cancer. Only on final pathology could we fully determine that a limited resection would have been acceptable. This underscores the diagnostic uncertainty that comes with large esophageal leiomyomas and also calls into question the utility of PET scan to aid in characterization of tumor aggressiveness.   These cases and updated literature review help to expand the awareness of the PET/CT limitations in determining aggressiveness of esophageal submucosal tumors.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 95502

Program Number: P513

Presentation Session: Poster Session (Non CME)

Presentation Type: Poster

View this Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search